chr10-70597677-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001083116.3(PRF1):​c.*376G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 587,542 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 1 hom. )

Consequence

PRF1
NM_001083116.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0100

Publications

0 publications found
Variant links:
Genes affected
PRF1 (HGNC:9360): (perforin 1) This gene encodes a protein with structural similarities to complement component C9 that is important in immunity. This protein forms membrane pores that allow the release of granzymes and subsequent cytolysis of target cells. Whether pore formation occurs in the plasma membrane of target cells or in an endosomal membrane inside target cells is subject to debate. Mutations in this gene are associated with a variety of human disease including diabetes, multiple sclerosis, lymphomas, autoimmune lymphoproliferative syndrome (ALPS), aplastic anemia, and familial hemophagocytic lymphohistiocytosis type 2 (FHL2), a rare and lethal autosomal recessive disorder of early childhood. [provided by RefSeq, Aug 2017]
PALD1 (HGNC:23530): (phosphatase domain containing paladin 1) Predicted to enable protein tyrosine phosphatase activity. Predicted to be involved in peptidyl-tyrosine dephosphorylation. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001083116.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRF1
NM_001083116.3
MANE Select
c.*376G>A
3_prime_UTR
Exon 3 of 3NP_001076585.1P14222
PRF1
NM_005041.6
c.*376G>A
3_prime_UTR
Exon 3 of 3NP_005032.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRF1
ENST00000441259.2
TSL:5 MANE Select
c.*376G>A
3_prime_UTR
Exon 3 of 3ENSP00000398568.1P14222
PRF1
ENST00000373209.2
TSL:1
c.*376G>A
3_prime_UTR
Exon 3 of 3ENSP00000362305.1P14222
PRF1
ENST00000862973.1
c.*376G>A
3_prime_UTR
Exon 2 of 2ENSP00000533032.1

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
238
AN:
152100
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000628
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00282
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00168
AC:
731
AN:
435326
Hom.:
1
Cov.:
0
AF XY:
0.00162
AC XY:
372
AN XY:
228946
show subpopulations
African (AFR)
AF:
0.00123
AC:
15
AN:
12214
American (AMR)
AF:
0.000121
AC:
2
AN:
16518
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13454
East Asian (EAS)
AF:
0.0000329
AC:
1
AN:
30392
South Asian (SAS)
AF:
0.0000494
AC:
2
AN:
40508
European-Finnish (FIN)
AF:
0.00161
AC:
47
AN:
29220
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1942
European-Non Finnish (NFE)
AF:
0.00241
AC:
641
AN:
265642
Other (OTH)
AF:
0.000904
AC:
23
AN:
25436
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00156
AC:
238
AN:
152216
Hom.:
1
Cov.:
32
AF XY:
0.00152
AC XY:
113
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.000626
AC:
26
AN:
41538
American (AMR)
AF:
0.000393
AC:
6
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00282
AC:
192
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00206
Hom.:
0
Bravo
AF:
0.00136

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Familial hemophagocytic lymphohistiocytosis 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.8
DANN
Benign
0.50
PhyloP100
0.010
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191816002; hg19: chr10-72357433; API